Literature DB >> 23354920

A higher glomerular filtration rate predicts low risk of developing chronic kidney disease in living kidney donors.

Shang-Feng Tsai1, Kuo-Hsiung Shu, Ming-Ju Wu, Hao-Chung Ho, Mei-Chin Wen, Chung-Kwang Su, Jong-Da Lian, Cheng-Hsu Chen.   

Abstract

BACKGROUND: The risk of developing chronic kidney disease (CKD) among living kidney donors (LKDs) is seldom included in evaluations of patients' outcomes. Potential risk factors and new criteria for estimating the glomerular filtration rate (eGFR) indexed for body surface area (BSA) were investigated with a view to prevent the development of CKD in LKDs.
METHODS: We conducted a retrospective study of LKDs from May 1983 to March 2011. The Mann-Whitney U test and χ(2) test were used to analyze the male versus female groups. Survival analysis was plotted as CKD-free survival and analyzed separately by different eGFR index classifications. The Cox regression model was used to identify potential risk factors for development of CKD.
RESULTS: A total of 105 LKDs with a mean age of 46.3 ± 12.5 years had a mean eGFR indexed for BSA of 88.9 ± 21.5 ml/min per 1.73 m(2). After a mean duration of 5.4 ± 4.9 years' follow-up, eGFR dropped to 61.4 ± 16.4 ml/min per 1.73 m(2) (p = 0.002). Median CKD-free survival was only 5.7 years. The difference between eGFR ≥ 80 ml/min per 1.73 m(2) and <80 ml/min per 1.73 m(2) was not statistically significant (p = 0.980). Multivariate Cox regression analysis showed that higher eGFR at donation (HR = 0.952, p = 0.0199) could be a protective factor. The receiver operating characteristic (ROC) curve for initial eGFR with best sensitivity of 52.78 % and specificity of 81.40 % was obtained with a cutoff value of 90.2 ml/min per 1.73 m(2) for preoperative eGFR. An eGFR of 90 ml/min per 1.73 m(2) yielded a significant survival curve (p = 0.0199) after 21 years of follow-up. Further classifications of eGFR >90 ml/min per 1.73 m(2) into 90-99 ml/min per 1.73 m(2), 100-109 ml/min per 1.73 m(2), and ≥110 ml/min per 1.73 m(2) were examined, but this survival curve was not statistically significant (p = 0.1247).
CONCLUSIONS: Living kidney donors will develop CKD after a long duration of follow-up if there is insufficiently high eGFR at donation. An eGFR above 90 ml/min per 1.73 m(2) before donation is the only factor that predicts prevention of CKD. Larger studies with longer duration of follow-up are necessary to clarify the clinical outcome of this postoperative CKD group, especially for patients with eGFR between 80 and 90 ml/min per 1.73 m(2).

Entities:  

Mesh:

Year:  2013        PMID: 23354920     DOI: 10.1007/s00268-013-1906-z

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  19 in total

1.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.

Authors: 
Journal:  Am J Kidney Dis       Date:  2002-02       Impact factor: 8.860

2.  Morbidity and mortality after living kidney donation, 1999-2001: survey of United States transplant centers.

Authors:  Arthur J Matas; Stephen T Bartlett; Alan B Leichtman; Francis L Delmonico
Journal:  Am J Transplant       Date:  2003-07       Impact factor: 8.086

3.  The influence of age on the renal response to water deprivation in man.

Authors:  J W Rowe; N W Shock; R A DeFronzo
Journal:  Nephron       Date:  1976       Impact factor: 2.847

4.  Perioperative mortality and long-term survival following live kidney donation.

Authors:  Dorry L Segev; Abimereki D Muzaale; Brian S Caffo; Shruti H Mehta; Andrew L Singer; Sarah E Taranto; Maureen A McBride; Robert A Montgomery
Journal:  JAMA       Date:  2010-03-10       Impact factor: 56.272

5.  Kidney donors live longer.

Authors:  I Fehrman-Ekholm; C G Elinder; M Stenbeck; G Tydén; C G Groth
Journal:  Transplantation       Date:  1997-10-15       Impact factor: 4.939

Review 6.  A Report of the Amsterdam Forum On the Care of the Live Kidney Donor: Data and Medical Guidelines.

Authors:  Francis Delmonico
Journal:  Transplantation       Date:  2005-03-27       Impact factor: 4.939

7.  Living kidney donors in need of kidney transplants: a report from the organ procurement and transplantation network.

Authors:  Mary D Ellison; Maureen A McBride; Sarah E Taranto; Francis L Delmonico; H Myron Kauffman
Journal:  Transplantation       Date:  2002-11-15       Impact factor: 4.939

8.  Low absolute glomerular filtration rate in the living kidney donor: a risk factor for graft loss.

Authors:  G Nordén; A Lennerling; G Nyberg
Journal:  Transplantation       Date:  2000-11-15       Impact factor: 4.939

9.  Long-term consequences of kidney donation.

Authors:  Hassan N Ibrahim; Robert Foley; LiPing Tan; Tyson Rogers; Robert F Bailey; Hongfei Guo; Cynthia R Gross; Arthur J Matas
Journal:  N Engl J Med       Date:  2009-01-29       Impact factor: 91.245

10.  All-cause mortality attributable to chronic kidney disease: a prospective cohort study based on 462 293 adults in Taiwan.

Authors:  Chi Pang Wen; Ting Yuan David Cheng; Min Kuang Tsai; Yen Chen Chang; Hui Ting Chan; Shan Pou Tsai; Po Huang Chiang; Chih Cheng Hsu; Pei Kun Sung; Yi Hua Hsu; Sung Feng Wen
Journal:  Lancet       Date:  2008-06-28       Impact factor: 79.321

View more
  3 in total

1.  The Outcomes of Living Kidney Donation from Medically Complex Donors: Implications for the Donor and the Recipient.

Authors:  Matthew Niemi; Didier A Mandelbrot
Journal:  Curr Transplant Rep       Date:  2014-03-01

2.  Risk Factors Associated with Decreased Renal Function after Hand-Assisted Laparoscopic Donor Nephrectomy: A Multivariate Analysis of a Single Surgeon Experience.

Authors:  Jinwook Lim; Yu-Gyeong Kong; Young-Kug Kim; Bumsik Hong
Journal:  Int J Med Sci       Date:  2017-02-08       Impact factor: 3.738

3.  Insufficient early renal recovery and progression to subsequent chronic kidney disease in living kidney donors.

Authors:  Yaerim Kim; Eunjeong Kang; Dong-Wan Chae; Jung Pyo Lee; Sik Lee; Soo Wan Kim; Jang-Hee Cho; Miyeun Han; Seungyeup Han; Yong Chul Kim; Dong Ki Kim; Kwon Wook Joo; Yon Su Kim; Hajeong Lee
Journal:  Korean J Intern Med       Date:  2022-04-13       Impact factor: 3.165

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.